EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Validating Low‐Dose Iohexol as a Marker for Glomerular Filtration Rate by In Vitro and In Vivo Studies

Qian Dong iD, Zhendong Chen iD, Jana Boland iD, Charalambos Dokos iD, Yohannes Hagos iD, Annett Kühne iD, Max Taubert iD, Dirk Gründemann iD, Uwe Fuhr iD

Clinical and Translational Science · 2025

DOI: 10.1111/cts.70141 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Qian Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Center for Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Iohexol, Glomerular Filtration Rate, Contrast Media. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clearance of an intravenous iohexol dose of 3235 mg is used to assess glomerular filtration rate (GFR), although systematic assessment of its pharmacokinetic (PK) properties is incomplete. The objectives of the present investigations were (i) to assess potential interactions of iohexol with important drug transporters, and (ii) whether a 259 mg dose could replace the current standard dose. In vitro, we evaluated whether iohexol inhibits or is transported by renal transporters (hOAT1/3, hOCT2, and hMATE1/2K) or other transporters (hOATP1B1/3, hOCT1, and hMDR1) using cell‐based and vesicle‐based systems. In vivo, we conducted a clinical trial with 12 volunteers with the administration of single intravenous doses of 3235 mg (“reference”) and 259 mg (“test”) using a changeover design. Plasma and urine samples were collected up to 24 h postdose. We assessed the dose linearity of iohexol pharmacokinetics using the standard bioequivalence approach and conducted a population PK analysis to characterize its profile. Our in vitro findings indicate that iohexol is neither a substrate nor a significant inhibitor of the transporters, suggesting it is unlikely to participate in transporter‐mediated drug–drug interactions in vivo. In the clinical trial, the test/reference ratio for plasma clearance, calculated as dose divided by the area under the plasma concentration–time curve, was 1.01 (90% confidence interval 0.968–1.05), confirming dose linearity. Population PK analysis further supported these results, showing no significant effect of dose on renal clearance and negligible nonrenal clearance of iohexol. Low‐dose iohexol is a suitable marker for precise GFR measurement, even when coadministered with other drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IohexolGlomerular Filtration RateContrast MediaHumansMaleAdultFemaleMiddle AgedBiomarkersDose-Response Relationship, DrugYoung AdultDrug InteractionsHealthy VolunteersKidneyAdministration, IntravenousHEK293 Cells

Stichwörter der Autor:innen

Iohexolclinical trialglomerular filtration ratetransporter‐mediated drug–drug interactions

Substanzen

IohexolContrast MediaBiomarkers

Autor:innen und Institutionen

  • Department of Pharmacology, Center for Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • PortaCellTec Biosciences GmbH, Göttingen, Germany.

ORCID-Profile: Qian Dong, Zhendong Chen, Jana Boland, Charalambos Dokos, Yohannes Hagos, Annett Kühne, Max Taubert, Dirk Gründemann, Uwe Fuhr

Zitieren

APA

Dong, Q., Chen, Z., Boland, J., Dokos, C., Hagos, Y., Kühne, A., Taubert, M., Gründemann, D., & Fuhr, U. (2025). Validating Low‐Dose Iohexol as a Marker for Glomerular Filtration Rate by In Vitro and In Vivo Studies. Clinical and Translational Science. https://doi.org/10.1111/cts.70141

Vancouver

Dong Q, Chen Z, Boland J, Dokos C, Hagos Y, Kühne A, et al. Validating Low‐Dose Iohexol as a Marker for Glomerular Filtration Rate by In Vitro and In Vivo Studies. Clinical and Translational Science. 2025. doi:10.1111/cts.70141

BibTeX
@article{Dong2025,
  author = {Dong, Qian and Chen, Zhendong and Boland, Jana and Dokos, Charalambos and Hagos, Yohannes and Kühne, Annett and Taubert, Max and Gründemann, Dirk and Fuhr, Uwe},
  title = {Validating Low‐Dose Iohexol as a Marker for Glomerular Filtration Rate by In Vitro and In Vivo Studies},
  journal = {Clinical and Translational Science},
  year = {2025},
  doi = {10.1111/cts.70141}
}
Kostenlos starten →